Monday Apr 14
Biotech Stocks Review -- Research on Achillion Pharma, Medivation, Mast Therapeutics, and Athersys
The losses were broad based as all the sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 644.74, down 1.07%, and the same has fallen by 2.36% in the previous three months.
Gilead Sciences: How Big a Threat is Merck?
For those wondering if Merck's hepatitis C drug would prove effective, the answer was a resounding yes.
Five Star Equities Issues New Research Reports on ACHN, MVIS, P and...
Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns.
The Motley Fool
Why Herbalife, Steel Partners Holdings, and Achillion Pharmaceuticals Jumped Today
Monday was largely a down day for the stock market, as the once-flying biotech sector again weighed on the broader indexes.